Bath & Body WorksWBO:LBRA -4.01%62 Altman Z-Score is 2.45 as of Jul. 03, 2026, which is 4% below its 10-year median of 2.56. GuruFocus rates WBO:LBRA with a GF Score™ of 62/100 and a GF Value™ of €29.16 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,113 Retail - Cyclical companies, Bath & Body Works ranks worse than 56.69% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 2.44 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
Bath & Body Works has a Altman Z-Score of 2.45, indicating it is in Grey Zones. This implies that Bath & Body Works is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Bath & Body Works's Altman Z-Score or its related term are showing as below:
WBO:LBRA'
s Altman Z-Score Range Over the Past 10 Years
Min: 0.43 Med: 2.56 Max: 3.94
Current: 2.44
During the past 13 years, Bath & Body Works's highest Altman Z-Score was 3.94. The lowest was 0.43. And the median was 2.56.
Bath & Body Works (WBO:LBRA) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Bath & Body Works Altman Z-Score Related Terms
Bath & Body Works Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Bath & Body Works's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:LBRA vs MNSO, RH, ASO: Altman Z-Score Comparison
For the Specialty Retail subindustry, Bath & Body Works's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bath & Body Works Altman Z-Score vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bath & Body Works's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Bath & Body Works's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Bath & Body Works's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.1052
+
1.4
*
-0.2603
+
3.3
*
0.2364
+
0.6
*
0.746
+
1.0
*
1.4595
=
2.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Bath & Body Works (WBO:LBRA) has a Altman Z-Score of 2.45 as of Jul. 03, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bath & Body Works and its competitors. This is near median its historical median of 2.56. Over the past decade, Bath & Body Works' Altman Z-Score has ranged from 0.43 to 3.94. According to the industry distribution chart, Bath & Body Works ranks #631 out of 1113 companies in the Retail - Cyclical industry, placing it in the top 56.7%.
Is Bath & Body Works' Altman Z-Score too high?
Bath & Body Works' current Altman Z-Score of 2.45 is near median its 10-year median of 2.56. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 3.94. The Retail - Cyclical industry median Altman Z-Score is 2.72. Bath & Body Works' value of 2.45 is 9.9% below this industry median. Based on the distribution chart, Bath & Body Works ranks #631 out of 1113 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Bath & Body Works has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bath & Body Works' Altman Z-Score compare to MNSO and RH?
According to the Retail - Cyclical industry distribution chart, Bath & Body Works ranks #631 out of 1113 companies for Altman Z-Score. This places Bath & Body Works in the lower half of its industry. The industry median Altman Z-Score is 2.72. Bath & Body Works' value of 2.45 is 9.9% below this benchmark. Historically, Bath & Body Works' own Altman Z-Score has ranged from 0.43 to 3.94 over the past decade. While the company's 10-year median is 2.56 vs. the industry median of 2.72, Bath & Body Works has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Retail - Cyclical company?
The median Altman Z-Score among Retail - Cyclical companies is 2.72, based on 1,113 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bath & Body Works's current Altman Z-Score of 2.45 is 9.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bath & Body Works and its competitors. For the Retail - Cyclical industry, the median Altman Z-Score is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bath & Body Works's current Altman Z-Score is 2.45, which is near median its own 10-year median of 2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bath & Body Works stock overvalued right now?
Based on GuruFocus' analysis, Bath & Body Works (WBO:LBRA) is currently considered Significantly Undervalued. The stock's GF Value™ is €29.16, compared to a current price of €18.79 — trading 35.6% below its estimated fair value. The current Altman Z-Score is 2.45, which is near median its 10-year median of 2.56 and 9.9% below the Retail - Cyclical industry median of 2.72. Bath & Body Works' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Bath & Body Works (WBO:LBRA), the current Altman Z-Score is 2.45 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bath & Body Works (WBO:LBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Bath & Body Works stock appears to be undervalued.
The current stock price of €18.79 is trading 35.6% below its estimated GF Value™ of €29.16.
GuruFocus considers Bath & Body Works to be Significantly Undervalued.
Key valuation signals for WBO:LBRA:
Altman Z-Score: 2.45 (near median its 10-year median of 2.56)
GF Value™: €29.16 vs. price of €18.79 (35.6% below fair value)
Industry Position: 9.9% below the Retail - Cyclical median (#631 of 1113)
No single metric tells the full story. See the WBO:LBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
62GF Score
Get the complete analysis for WBO:LBRA
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:LBRA has been successfully added to your 
